Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto 390-8621, Japan.
Neurochem Res. 2011 Nov;36(11):2127-35. doi: 10.1007/s11064-011-0537-8. Epub 2011 Jun 26.
To clarify the neuroprotective property of ceruloplasmin and the pathogenesis of aceruloplasminemia, we generated ceruloplasmin-deficient (CP⁻/⁻) mice on the C57BL/10 genetic background and further treated them with a mitochondrial complex I inhibitor, rotenone. There was no iron accumulation in the brains of CP⁻/⁻ mice at least up to 60 weeks of age. Without rotenone treatment, CP⁻/⁻ mice showed slight motor dysfunction compared with CP⁺/⁺ mice, but there were no detectable differences in the levels of oxidative stress markers between these two groups. A low dose of rotenone did not affect the mitochondrial complex I activity in our mice, however, it caused a significant change in motor behavior, neuropathology, or the levels of oxidative stress markers in CP⁻/⁻ mice, but not in CP⁺/⁺ mice. Our data support that ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity, probably through its antioxidant properties independently of its function of iron metabolism.
为了阐明铜蓝蛋白的神经保护特性和血铜蓝蛋白缺乏症的发病机制,我们在 C57BL/10 遗传背景下生成了铜蓝蛋白缺陷(CP⁻/⁻)小鼠,并进一步用线粒体复合物 I 抑制剂鱼藤酮对其进行处理。CP⁻/⁻小鼠的大脑中至少在 60 周龄时没有铁积累。没有鱼藤酮处理时,CP⁻/⁻小鼠与 CP⁺/⁺小鼠相比表现出轻微的运动功能障碍,但两组之间氧化应激标志物的水平没有检测到差异。低剂量的鱼藤酮不会影响我们小鼠的线粒体复合物 I 活性,但它会导致 CP⁻/⁻小鼠的运动行为、神经病理学或氧化应激标志物的水平发生显著变化,而 CP⁺/⁺小鼠则没有。我们的数据支持铜蓝蛋白通过其抗氧化特性来抵抗鱼藤酮诱导的氧化应激和神经毒性,可能与其铁代谢功能无关。